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Abstract: Nanomaterials hold much promise for biological applications, but they require 
appropriate functionalization to provide biocompatibility in biological environments.  For non-
covalent functionalization with biocompatible polymers, the polymer must also remain attached 
to the nanomaterial after removal of its excess to mimic the high dilution conditions of 
administration in vivo.  Reported here are the synthesis and utilization singly-substituted 
conjugates of dextran and a phospholipid (Dextran-DSPE) as stable coatings for nanomaterials.  
Suspensions of single walled carbon nanotubes were found not only to be stable to phosphate 
buffered saline (PBS), serum, and a variety of pH’s after excess polymer removal, but also 
provide brighter photoluminescence than carbon nanotubes suspended by poly(ethylene glycol)-
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DSPE.  In addition, both gold nanoparticles (AuNPs) and gold nanorods (AuNRs) were found to 
maintain their dispersion and characteristic optical absorbance after transfer into Dextran-DSPE, 
and were obtained in much better yield than similar suspensions with PEG-phospholipid and 
commonly used thiol-PEG.  These suspensions were also stable to PBS, serum, and a variety of 
pH’s after removal of excess polymer. Dextran-DSPE thus shows great promise as a general 
surfactant material for the functionalization of a variety of nanomaterials, which could facilitate 
future biological applications. 
Introduction 
Owing to their unique photophysical and electronic properties, new types of nanomaterials 
have been implemented in recent years for both in vitro and in vivo biological applications.  
Particular attention has been paid to those nanomaterials that absorb light or fluoresce in the near 
infrared (NIR) range, which boasts substantial penetration into living tissue.1 Examples include 
single-walled carbon nanotubes (SWNTs), which exhibit high NIR absorbance2 and 
fluorescence3 and strong Raman scattering signatures.4, 5  SWNTs and other carbonaceous 
materials6 have been used as transporters of molecules into cells,2, 7-9 as well as both fluorescent 
labels10-12 and contrast agents for NIR-induced cell heating.2  Gold nanoparticles (AuNPs)13, 14 
and nanorods (AuNRs),15, 16 the latter of which have peak absorbances that can reach the NIR 
range, have been used as biomolecular sensors,17, 18 cell markers,19 and x-ray contrast agents.20  
Finally, quantum dots (QDs),21, 22 which boast tunable, narrow fluorescence emissions, have 
been utilized for multiplexed imaging.23   
Despite the variety of structures and properties of these nanomaterials, to be used in vivo they 
all must satisfy the requirements of biocompatibility including water solubility, suppressed 
immune response, and lack of toxicity, which is highly dependent on surface functionalization 
 3 
chemistry. In most cases, functionalization is provided by attaching capping ligands or 
surfactants that also help to prevent aggregation of the nanomaterials and subsequent loss of 
photophysical properties.  While small molecule ligands will not stay bound under high dilution 
conditions, polymer coatings have been shown to be more stable to changes in aqueous media 
and can provide more complete coverage of the nanomaterial surface.  Thus, an ideal polymer 
coating for medical applications would: 1) preserve a stable coating even under high dilution 
conditions, as would be expected in vivo; 2) prevent non-specific binding of proteins and 
macrophages that may result in high background and low blood circulation time in ex vivo and in 
vivo applications, respectively, 3) provide accessible functional groups for the augmentation of 
targeting groups and additional layers of passivation, 4) prevent the rebundling or aggregation of 
nanomaterials under various conditions and 5) maintain the unique physical properties inherent 
to the nanomaterial. 
For this purpose, a variety of polymeric systems have been developed to form stable protective 
coatings, by covalent or non-covalent means, around these nanomaterials.  In most cases, 
poly(ethylene glycol) (PEG) is the chief component in many passivating polymeric assemblies, 
from stealth liposomes24, 25 to hybrid polymer-carbon nanotubes2, 7, 26 and quantum dot 
coatings.27  Another, less commonly used biocompatible polymer is dextran,28, 29 a naturally-
occurring polymer consisting of α(1?6)-linked glucose monomers that also contains about 5% 
branching at the 4-position as produced in Leuconostoc mesenteroides.  The structure of dextran 
is very interesting for a few reasons, especially in contrast with PEG.  First, the hyperbranched 
structure and packed interior of the dextran results in its globular shape persistence above Mn ~ 
10,000,30 which makes it similar to other manmade hyperbranched structures like dendrimers31-35 
and hyperbranched polyols.36, 37  This, in turn, may allow a coating more resistant to protein 
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adhesion than a linear polymer.  As hyperbranched structures often require multiple steps or 
precise synthetic conditions to obtain useful polymer scaffolds, a naturally occurring analog may 
save much time and effort towards the synthesis of novel hyperbranched materials.  Second, its 
polyhydroxylated structure makes dextran a very hydrophilic polymer, which may provide a 
sharp contrast with any hydrophobic components and thus provide facile self-assembly.  Finally, 
dextran contains many accessible hydroxyl groups, which may be functionalized further with 
short PEG units to obtain hyperbranched polymeric structures that show improved circulation in 
vivo when compared to linear analogs.26, 38  In addition, these sites allow significant loading of 
targeting groups like the RGD peptide motif39 or mannose.40  This same property, however, often 
precludes the use of dextran in structure-specific applications because of the difficulties in 
attaching specific numbers of functional groups to the dextran.41-43   
In this paper, we report the synthesis of a phospholipid-dextran conjugate, in which the 
phospholipid, 1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE), is bound at a single 
point to the reducing end of the dextran.  We found that not only was this material able to form 
self-assemblies easily in water, but also formed stable coatings on carbon nanotubes, gold 
nanoparticles, and gold nanorods.  These dextran-nanomaterial coatings showed stability to a 
range of pH’s, salt conditions, and introduction of serum.  Finally, the dextran-coated materials 
showed improved photophysical properties when compared with similar suspensions in 
PEGylated-phospholipid and commonly used thiol-terminated PEG (PEG-SH).  Specifically, 
SWNTs coated with phospholipid-dextran showed a several-fold enhancement in 
photoluminescence, which could facilitate NIR imaging applications of nanotubes, and 
phospholipid-dextran was able to suspend AuNRs, which could not be achieved with PEGylated-
phospholipid.  Thus, phospholipid-dextran conjugates have boasted versatile and high quality 
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suspensions that to our knowledge have been previously unobserved in the adaptation of 
nanomaterials for biological applications. 
 
Materials and Methods 
General Materials and Methods.  Fluorescence emission and excitation spectra were 
obtained using an ISA/SPEX Fluorolog 3 equipped with a 450 W Xe lamp, double excitation and 
double emission monochromators and a digital photon-counting photomultiplier.  Slit widths 
were set to 5.0 nm band-pass on both excitation and emission monochromators.  UV-Vis spectra 
were taken on a Cary 6000i spectrophotometer.  Carbon nanotube spectra were taken in double 
beam experiment using two matching 1-mm pathlength glass cuvettes.  Nanoparticle and 
nanorods were measured in a 1-cm path-length quartz cuvette in a single beam experiment.  1H 
Nuclear Magnetic Resonance spectra were obtained on an Oxford AS400 at 400 MHz.  NMR 
chemical shifts are reported in ppm and calibrated against DMSO-d6 (δ 2.49).  Dynamic Light 
Scattering measurements were obtained on a Brookhaven Instruments 90Plus Particle Size 
Analyzer.  The polydispersity reported is the ratio of the statistical variance of the sample to the 
square of the mean diameter, as calculated by the instrument software.  Atomic Force 
Microscopy (AFM) was conducted on a Multimode Nanoscope IIIa AFM system (Veeco). 
Photoluminescence excitation (PLE) measurements in the NIR were performed utilizing a 
home-built setup. A short arc lamp (Osram XBO 75W/2 OFR 75W Xenon lamp installed into 
Oriel 66907 Arc Lamp Source) and a monochromator (Oriel 7400 Cornerstone 130 
monochromator) were used to supply excitation light in the 550 nm – 840 nm range in 10 nm 
steps. The excitation light was focused onto a sample placed in a 1 mm path quartz cuvette. The 
room temperature sample photoluminescence was collected at the opposite cuvette wall and the 
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PL spectrum was recorded using a second monochromator (Acton SpectraPro 2300i) and a liquid 
nitrogen-cooled InGaAs array detector (Princeton Instruments OMA V 1024-2.2 LN) in the 900–
1500 nm range. As-obtained PL spectra were scaled by the measured excitation power (measured 
using Oriel 71580 calibrated Si photodiode) before obtaining a PLE spectrum by interpolating 
the thirty measured PL spectra.  The bandpass used for emission and excitation was 15nm.   
 Synthesis of Dextran-DSPE (1).  In a scintillation vial with stirbar, 200 mg dextran (0.0114 
mmol, Mn ~ 17,500; MP Biomedicals, Inc.) and 32 mg N-hydroxysuccinimide (NHS, 0.286 
mmol, Pierce) were dissolved in 8 mL dry DMSO (Fluka).  This solution was kept at 60°C until 
all solid dissolved, then cooled to RT.  122 mg N,N’-dicyclohexylcarbodiimide (DCC, 0.586 
mmol, Aldrich) was added and the mixture agitated until the DCC was observed to dissolve.  In a 
separate vial, 88 mg 1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE, 0.117 mmol, 
Lipoid LLC) and 34 µL triethylamine (0.228 mmol, EMD) were combined in 2 mL chloroform 
(EMD) and sonicated briefly until any clumps of solid were dispersed in the solvent.  This 
suspension was added to the first solution carefully to avoid spilling along the sides.  The 
combined suspension was stirred at 60°C for 2 d, then cooled to RT.  The suspension was then 
subjected to an air stream until the presence of chloroform could no longer be observed by smell.   
A mixture of the remaining suspension and 24 mL distilled water were transferred to a centrifuge 
tube, centrifuged at 10,000 g for 30 min, and coarsely filtered.  The filtrate was transferred to a 
3500 MWCO regenerated cellulose dialysis tube (Fisher) and dialyzed 3 d against several 
changes of distilled water.  Finally, the dialysate was centrifuged at 10,000 g for 30 min, 
refiltered through a 200 nm pore-size filter to remove any remaining solid, and freeze-dried to 
obtain a fluffy, white powder (170 mg, 81%).  This final purification was repeated prior to 
characterization.  1H NMR (DMSO-d6):  δ 0.84-0.90 (m, 6H), 1.21-1.32 (m, 32H), 1.49-1.53 (m, 
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4H), 2.25-2.30 (m, 6H), 3.05-3.87 (m, ~550H), 4.46-4.62 (m, 108H), 4.62-4.78 (m, 108H), 4.78-
5.02 (m, 216H). 
Determination of Critical Micelle Concentration.  10 µL of a stock solution containing 0.10 
mg/mL pyrene in chloroform was added to each of eight vials.  These vials were placed under 
vacuum and allowed to dry for at least 30 min.  Solutions of 1 in phosphate buffered saline 
(PBS) were made at concentrations indicated in the text, and 3 mL of the appropriate 
concentration was added to each vial.  The vials were agitated gently overnight to allow pyrene 
uptake.  The fluorescence emission of pyrene (λexc = 340 nm) was measured for each solution.  
After subtracting a background of any PBS fluorescence, the ratio of the emission at 373 nm to 
the emission at 383 nm was determined and plotted against the log of the concentration of 1.  
The inflection point as determined by the best fit of the data above and below the CMC gave a 
CMC of 1.8 µM.   
Suspension of SWNTs.  Excellent SWNT suspensions were obtained via the following steps.  
First, a 3.6 mg/mL (200 µM) solution of dextran-17-DSPE (1) in deionized ultrafiltered water 
was prepared by adding 1 to the water, sonicating for 5 min, then centrifuging the mixture for 10 
min at 25,000 g.  The supernatant was then used for suspension. The rest of this method of 
suspending nanotubes has been described previously.2  Briefly, 0.75-2.0 mg raw HiPCO SWNTs 
(Unidym, Inc. >65% carbon) were placed in a 20 mL scintillation vial, followed by 4 mL of the 
above solution for every 1.0 mg of NTs in the vial.  This mixture was vortexed for a few min 
until almost all of the NTs were below the solvent line, then sonicated 30 min.  The sonicator 
water bath was replaced with fresh RT distilled water and the suspension was sonicated an 
additional 30 min.  The dark suspension was centrifuged for 6 h at ca. 25,000 g, and the 
supernatant was recovered carefully via pipette for subsequent experiments.  The excess 
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surfactant was removed through vacuum filtration through a 0.1 µm polycarbonate membrane 
(Millipore) and extensive washing with deionized ultrafiltered water.  The best results were 
obtained by not allowing the filter to dry, although most SWNTs that adhered to the filter could 
be resuspended through brief (< 5 min) vortexing or bath sonication of the filter in water.  For 
comparison to solutions obtained prior to excess polymer removal, the filtered solution was 
concentrated to the original sample volume via a 100 kDa centrifuge filter (Millipore). 
Suspensions of SWNTs in mPEG(5000)-DSPE (Laysan Bio) were prepared as described in the 
literature.2 
Suspensions of Gold Nanoparticles.  5 mg of 1, mPEG(5000)-DSPE, or PEG(5000)-SH 
(Nektar) were dissolved in 5 mL of a citrate-stabilized 20 nm gold colloid solution (Sigma).  The 
mixture was sonicated 15 min, then transferred to a 3500 MWCO regenerated cellulose tubing a 
dialyzed overnight with several changes of distilled water.  The resultant solution was then 
centrifuged at 25,000 g for 10 min, which caused the NPs to form a pellet.  The supernatant was 
removed and fresh water was added.  This washing procedure was performed four times total to 
remove excess polymer, after which fresh water was added to bring the final volume to 5 mL.   
Gold Nanoparticle Suspension Stability Tests.  For PBS stability tests, 450 µL of the Au NP 
solution was combined with 50 µL 10X PBS (Gibco).  For pH tests, 450 µL of the solution was 
combined with 50 µL of an appropriate solution of HCl or NaOH.  For serum tests, 450 µL 
solution, 50 µL 10X PBS, and 500 µL Fetal Bovine Serum (Gibco).  All test solutions were 
agitated overnight prior to UV-Vis measurement and photographing. 
Synthesis of Gold Nanorods.  Gold nanorods were synthesized via a literature procedure by 
Nikoobakht and El-Sayed.16  For the experiments described in the main text, the approximate 
size of the nanorods is 35x15x15 nm as determined by matching the obtained absorption 
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spectrum (Figure 5A) with those in their report.  Immediately prior to use, the cetyl 
trimethylammonium bromide (CTAB)-stabilized NR suspensions were sonicated at least 10 min 
to redissolve any precipitated CTAB. 
Suspension of Gold Nanorods.  To 4 mL CTAB-stabilized NRs suspension, 1 mL N-
methylformamide (NMF, Aldrich) was added.  The suspension was mixed and then centrifuged 
at 25,000 g for 10 min to remove CTAB.  The supernatant was removed and replaced with a 
fresh 4:1 water:NMF mixture, vortexed to resuspend the pelleted NRs, and recentrifuged.  The 
supernatant was removed, 8 mL water was added to the pelleted NRs. The mixture was vortexed 
back into solution, and 8 mg of either 1 or mPEG(5000)-DSPE was dissolved.  The suspension 
was sonicated 15 min, then transferred to a 3500 MWCO regenerated cellulose tubing and 
dialyzed overnight with several changes of distilled water.  The resultant solution was then 
centrifuged at 25,000 g for 10 min, which caused the NRs to pellet.  The supernatant was 
removed and fresh water was added.  This washing procedure was performed four times total to 
remove excess polymer surfactant, after which the final volume was 5 mL.   
Gold Nanorod Stability Tests.  Stability tests were performed as with the NPs described 
above. 
 
Results and Discussion 
Synthesis of Dextran-DSPE.  Early in our work, we found that dextran alone was unable to 
provide a stable suspension of nanotubes.29  Studies in our labs have shown that PEG conjugates 
of 1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE) are able suspend carbon nanotubes 
well to prevent aggregation under serum conditions with excess polymer removed.2, 26  In 
addition, phospholipids also boast natural occurrence, biocompatibility, and strongly 
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hydrophobic components, all of which provide advantages over other nanotube binding groups 
such as pyrene44 or porphyrins.45  Thus, the challenge was to join the DSPE and dextran together.   
To mimic the PEG-DSPE system, we decided to attach DSPE to the dextran at a single point 
only.  This can be done at the reducing, or anomeric, end of the dextran, which differs in 
reactivity from the hydroxyl groups on the rest of the polymer.46  Previous syntheses that utilized 
the reducing end of dextran first required the coupling of a bifunctional amine by reductive 
amination, followed by the attachment of a molecule of interest.46, 47  However, in many cases 
the yield of the reductive amination is limited,46 and it would be very difficult to separate free 
dextran from a phospholipid conjugate.  We reasoned that a one-step ligation using a different 
method would not only decrease the number of steps involved in the synthesis but also improve 
the efficiency of purification of the final dextran conjugates. 
In common syntheses of glycosylamines, the alkyl and sugar components are joined simply by 
acid-catalyzed condensation of the amine to form a stable cyclic aminal.48  Interestingly, we 
could find no literature reports for this reaction having been performed with higher molecular 
weight dextran.  We surmised that given the higher molecular weight of the dextran, the reaction 
would require stronger conditions.  However, highly elevated temperatures resulted in a 
yellowing of the DSPE and low yield, which has been attributed to a thermally-promoted 
rearrangement special to phosphoethanolamines.49   
Instead, a chemically-promoted dehydration was tried with an excess of N-N’-
dicyclohexylcarbodiimide being added as a dehydration agent, along with N-hydroxysuccinimide 
both to facilitate the DCC condensation and as a weak acid (Scheme 1).  A similar strategy, 
albeit with CuCl as a catalyst, has been used to join phenols to oligosaccharides.50  Gratifyingly, 
after stirring at 60°C for 2 d, the DSPE was found to add to the dextran in a 1:1 ratio by 1H 
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NMR.  A 4:1 cosolvent mixture of DMSO and chloroform was required to both solubilize the 
dextran and suspend the DSPE to allow the reaction to occur.    
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Scheme 1: Synthesis of dextran-DSPE at the reducing end of dextran. 
To our knowledge, this is the first time that a phospholipid has been conjugated by a single-
point reaction with dextran.  First, it should be stated that the coupling cannot be as a result of 
DMSO-induced Moffatt oxidation, since the reaction also worked in a DMF:toluene mixture.  
Second, in test trials it was found that a reaction of dextran and DSPE with all of the above 
reagents except for DCC the reaction proceeded very slowly.  Without NHS, the reaction did not 
proceed at all.  From these observations, we propose that this reaction may be operating under 
two competing mechanisms.  By itself, the NHS may function as a weak acid and promote the 
aminalation of the DSPE to a certain extent, which has been observed in acid-catalyzed synthesis 
of glycosylamines.48 Other procedures have reported the synthesis of O-glucopyranosyl-N-
hydroxysuccimides that were based on Lewis Acid assisted coupling of NHS to the anomeric 
portion of glucose,51  which were then reacted with amines after addition of EDC.52  In this case, 
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the NHS acted as a bifunctional linkage between the glucose and the amine.  Thus the dominant 
reaction pathway may proceed through a DCC-induced dehydration with NHS stabilizing the 
active intermediate, followed by amine attack to form the aminal.  While more studies are 
certainly warranted to conclude a mechanistic pathway, it should be noted that this reaction is 
difficult to analyze owing to the complicated structures and solubility requirements of its 
reactants.   
Self-assembly of 1.  An interesting property of each of the components of this product is their 
selective solubility in most solvents: dextran is only soluble in water and very strongly polar 
aprotic solvents, while phospholipids are more soluble in fairly non-polar media and tend to self-
assemble in more polar solvents.  Thus, in aqueous conditions hydrophobicity-driven self-
assembly would be expected.  To determine the presence of assemblies, varying amounts of 1 
were dissolved in PBS and incubated with pyrene overnight.  As more pyrene is encapsulated in 
a hydrophobic environment, the fine spectra of the pyrene unimer change, resulting in a change 
in the peak heights of the emission spectra.53, 54  A plot of the ratios of fluorescence emission at 
373 nm to 383 nm vs. log of concentration (Figure 1A) shows a sharp change around 1.8 µM, 
indicating the Critical Micelle Concentration (CMC), a value is very similar to that of PEG-
DSPE.55  It should be noted that at higher concentrations of 1, a very small amount of insoluble 
solid was present.  We suspected either that this was excess DSPE, which would interfere with 
the assembly, or that the concentration of 1 had become large enough to induce the formation of 
other superstructures.  However, simply centrifuging away the solid was sufficient to obtain 
solutions appropriate for Dynamic Light Scattering, which showed the presence of assemblies 
that were 70 nm in diameter (Figure 1B).  Given that the average hydrodynamic diameter of each 
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dextran molecule is ca. 6-7 nm56 and the length of the phospholipid is approximately 3-3.5 nm, 
this would indicate at least a partial bilayer to account for the added size of the assembly.   
 
Figure 1: (A) Ratio of fluorescence emission of pyrene at 373 nm to 383 nm (λexc = 340 nm) vs. 
log of concentration of dextran-DSPE (spectra found in Figure S2).  This ratio indicates a change 
in pyrene monomer vibronic band intensities that correlates with a change in pyrene solvent 
environment, or in this case micelle formation.  The inflection point in the curve indicates a 
Critical Micelle Concentration of ca. 1.8 µM.  (B) Dynamic Light Scattering of 200 µM 1 in 
water shows assemblies of 70 nm in diameter, with an average particle polydispersity of 0.100.   
Functionalization of Carbon Nanotubes by 1.  Carbon nanotubes are especially challenging 
materials to suspend, because they require non-covalent functionalization to maintain their 
important spectroscopy properties, such as NIR absorption features,2 photoluminescence,3 and 
Raman scattering.4 Our dextran-DSPE  proved to be useful amphiphiles for nanotube suspension.  
To make dextran-DSPE-suspended SWNTs, dry, raw HiPCO-produced SWNTs were sonicated 
for 1 h in the presence of a predissolved, precentrifuged 200 µM solution of 1 in water, followed 
by removal of unsuspended aggregates by centrifugation.  The UV-Vis spectrum of this material 
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is shown in Figure 2A, and depicts a typical HiPCO-produced carbon nanotube UV-Vis 
spectrum.3 
 
Figure 2: UV-Vis-IR absorption spectra of SWNTs encapsulated by 1 after 6 h centrifugation at 
25,000 g (orange) and after removal of excess 1 by vacuum filtration (blue), and after transfer of 
this solution into PBS.  (B) To demonstrate stability of suspension to serum, the suspension was 
transferred to a 1:1 mixture of PBS:FBS (red).  Despite two weeks of incubation, the suspension 
yield did not decrease significantly (blue).  (C) Exposure to different pH conditions led only to a 
decrease in suspension yield for pH 2, while the other suspensions gave exactly the same 
spectrum.  (D) Photograph of SWNT suspensions depicted in (A) and (C) as indicated.  The 
black color is typical of good SWNT suspensions. 
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While suspensions of carbon nanotubes can be obtained with a variety of different 
surfactants,57 few are both non-toxic and able to withstand a variety of different conditions 
without excess surfactant present.  In our case, removal of excess 1 by vacuum filtration through 
a 100nm-pore polycarbonate filter gave a spectrum very similar to that obtained with excess 
intact (Figure 2A), and the completeness of excess removal was confirmed by the absence of free 
Dextran-DSPE in images obtained by AFM (Figures S2 and S3), which in poorly washed 
samples would be visible in aggregates of about 100 nm.  Moreover, the nanotube suspensions 
were stable without aggregation in PBS and other biological buffer solutions.  As other groups 
have done,58 we ascribe the ability of 1 to suspend SWNT to the formation of hydrophobic zones 
created in the self-assembly of 1, followed by the sequestering of the SWNTs in that assembly. 
Following these initial promising studies, the DSPE-dextran-nanotube conjugates were 
subjected to more stringent tests.  First, the PBS suspension was diluted halfway with Fetal 
Bovine Serum (FBS) to mimic conditions in blood circulation.  The UV-Vis spectra in Figure 2B 
show that the nanotubes were stable to these conditions both after 24 h and two weeks.  The 
carbon nanotube suspensions were also subjected a variety of different acid and base conditions 
to test the stability after overnight incubation.  At pH 4, pH 10, and pH 12, the carbon nanotubes 
showed no evidence of bundling or precipitation, as the UV-Vis spectra of each of these all 
coincide (Figure 2C).  At pH 2, there was a slight loss in signal.  This may be due to degradation 
of dextran under acidic conditions, either due to hydrolysis of the glycosidic linkages within 
dextran or hydrolysis of the dextran-DSPE bond. 
The photoluminescence of the suspensions of nanotubes were also quite favorable.  It can be 
difficult to maximize the photoluminescence of carbon nanotubes, which depends on three 
factors: 1) the debundling of the SWNTs, 2) the number of defects on the SWNTs, and 3) the 
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type of stabilizing agent used to create the suspensions.  Shown in Figure 3A are 
photoluminescence emission (PLE) spectra of a washed, Dextran-DSPE suspension of SWNTs 
in PBS.  Peaks can be seen corresponding to (7,5), (7,6), (8,4), and (9,4), which is typical for a 
HiPCO-produced sample.59  Interestingly, this sample proved to have a significantly better 
overall photoluminescence than a similarly prepared sample of PEG-DSPE-produced SWNTs 
(Figure 3B).  There are a few possible reasons for this.  First, the persistent size of the dextran 
may prevent the SWNTs from rebundling better than PEG-DSPE, leading to more single tubes in 
solution.  Second, use of dextran may have provided a milder sonication environment that leads 
to fewer defect sites on the tubes, or may have left longer tubes in solution.  However, further 
investigations are needed to elucidate these factors.  
 
Figure 3:  Photoluminescence excitation spectra of SWNTs (normalized to tube concentrations 
measured by UV-Vis) suspended in (A) 1 and (B) mPEG(5000)-DSPE after removal of excess 
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polymer.  (C) Fluorescence emission spectra (λexc = 650 nm) of SWNTs in 1 (red) and 
mPEG(5000)-DSPE (black). 
One of the applications of stable, biocompatible suspensions of carbon nanotubes is their use 
as fluorescence tags for both ex vivo and in vivo imaging.  SWNTs contain both excitation and 
emission wavelengths within the tissue transparency window, which corresponds to an area of 
the visible and NIR spectrum to which living tissue has increased transparency.1  Shown in 
Figure 3C is the fluorescence emission at 650 nm excitation. The overall fluorescence emission 
of the 1-suspended tubes shows approximately a four-fold increase in total fluorescence emission 
over the PEG-DSPE-suspended tubes.10, 26, 60  This, in practice, would correspond to a fourfold 
increase in sensitivity, which would be beneficial for both cell10 and in vivo imaging. 
Stable Functionalization and Suspension of Gold Nanoparticles and Nanorods.  The most 
common method of gold nanoparticle functionalization is through a gold-thiol bond, but both 
sodium dodecylsulfate (SDS)61 and Triton-X-100,62 a PEG-based amphiphile, have previously 
been used to template the synthesis of and stabilize gold nanoparticles. Our DSPE-dextran was 
shown to be a suitable coating for gold nanomaterials as well.  This was shown initially with 
spherical gold nanoparticles (AuNPs), which are commercially available.  First, a citrate-
stabilized gold colloid solution was combined with 1 and then sonicated to displace the citrate.  
Immediately, a slight color change could be observed, which we surmised was a change in 
plasmon resonance as a result of a change in surface coating and thus the dielectric environment 
of the AuNP.63-65  The excess citrate was dialyzed away to ensure full assembly of the polymer 
on the nanoparticles, and then excess polymer was removed via a series of centrifuge washings 
to obtain a stable, washed suspension of gold nanoparticles.  In contrast, mPEG(5000)-DSPE 
gave stable suspensions of gold NP, but only at about 90% of the yield found with 1, and AuNPs  
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coated with PEG-SH after removal of excess PEG-SH showed aggregation of Au NPs (Figure 
4A).   
These particles also showed excellent stability in other aqueous media.  As shown in Figure 
4B, dilution into PBS did not change the shape of the UV-Vis trace, but under the same 
conditions citrate-stabilized particles aggregate and precipitate from solution.  The DSPE-
dextran coated AuNPs were also stable to serum (Figure 4B) with characteristic optical 
absorbance largely intact. As with the carbon nanotube suspensions, the AuNP suspensions also 
showed good stability towards other pH’s, with the greatest stability at pH’s 4 and 10 and the 
least stability at pH 2 (Figure 4C).  However, it should be noted that part of this decrease in 
absorbance may be due to a change in the surface plasmon due to the changing salinity of the 
media with higher acid or base addition. 
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Figure 4:  (A) UV-Vis absorption spectra of 20 nm AuNPs suspended by 1 (blue), mPEG(5000)-
DSPE (red), and PEG-thiol (brown) in water.  Excess polymer has been washed away four times 
for 1 and mPEG(5000)-DSPE, while the PEG-thiol has only been washed twice.  The large peak 
at 660 nm for PEG-thiol is due to NP aggregates in the suspension formed after removal of 
excess PEG-thiol from the solution.  (B) UV-Vis spectra of 20 nm AuNPs suspended by 1 in 
PBS (green) and 1:1 PBS:FBS (brown).  The small peak at 425 nm is due to the large absorbance 
of FBS in this region. (C) UV-Vis spectra of 20 nm AuNPs suspended by 1 after excess polymer 
removal at pH 2 (green), 4 (brown), 10 (purple) and 12 (red).  (D) Photographs of solutions 
depicted in (B) and (C).  The orange color in the PBS:FBS solution comes from the pink AuNPs 
and the yellow serum, and the aggregated citrate-suspended particles can be seen at the bottom of 
their vial. 
Next, DSPE-dextran functionalization was attempted with cylindrical gold nanorods.16 AuNRs 
are of particular interest because their longitudinal surface plasmon resonances can be tuned to 
fall in the NIR range.  These suspensions were made in a similar manner to the gold 
nanoparticles, followed by removal of excess 1.  While there was a decrease in nanorod yield as 
a result of the transfer, the peaks remained sharp (Figure 5A).  There was also a slight red shift in 
the longitudinal plasmon peak at 636 nm and blue shift in longitudinal peak at 515 nm, 
presumably due to the change in environment around the nanorod.  Also, a shoulder appears at 
around 750 nm, which is most likely due to slight aggregation of the rods.64  CTAB-encapsulated 
NRs, however, showed a dramatic decrease in absorbance and loss of color after washing away 
excess surfactant.  Thus functionalization by 1 stabilizes the AuNRs against precipitation. The 
NRs also remained similarly suspended after transfer into PBS solutions and serum (1:1 
PBS:FBS) (Figure 5B).  While there is a slight red shift of the longitudinal plasmon peak and 
 20 
blue shift of the transverse peak, the overall intensity remains fairly constant.  Finally, as before, 
the DSPE-Dextran-suspended NRs were tested for their stability to different pHs.  As with the 
NTs, the best suspensions were at pH 4, 10, and 12, while the NRs incubated at pH 2 showed a 
severe loss of color.  We speculate that again the loss of signal is due to dextran instability at 
very acidic pH. 
Figure 5:  (A) UV-Vis-IR absorption spectra of AuNRs suspended by CTAB as-made (brown), 
after removal of CTAB (red), and suspended by 1 after excess polymer removal (green).  (B)  
UV-Vis spectra of AuNRs suspended by 1 after excess polymer removal in PBS (green) and 1:1 
PBS:FBS (red).  (C)  UV -Vis spectra of AuNRs suspended by 1 after excess polymer removal at 
pH 2 (blue), 4 (brown), 10 (red) and 12 (green).  (D) Photographs of solutions depicted in (B) 
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and (C) as indicated.  The 1:1 PBS:FBS solution is green due to the blue color from the AuNRs 
and the yellow color from the serum. 
Since Dextran-DSPE self-assembles readily in aqueous solution but lacks a functional group 
that binds specifically to the surface of a nanomaterial, most likely the nanomaterials were 
encapsulated within the Dextran-DSPE assembly.  As with Triton-X and SDS, it appears that the 
Dextran-DSPE encapsulated the gold nanomaterials via hydrophobic interactions with the metal 
surface, while attempts to suspend AuNRs with PEG-SH resulted in a complete loss of UV-Vis 
absorbance after excess PEG-SH removal, most likely due to aggregation (unpublished data).  
Thus, this material may have implications for alternate forms of gold nanomaterial suspension 
beyond gold-thiol bonds.  However, AuNRs could not be suspended by mPEG(5000)-DSPE 
either (Figure S4), which complicates an explanation based simply on micelle formation.  We 
speculate that the reason that 1 works better is that the structure of the hyperbranched dextran is 
able to prevent the reassociation of the nanorods more effectively than the linear PEG, providing 
a more stable coating.  As discussed in the introduction, the crowded interior of dextran provides 
a shape persistence not generally found in linear polymers such as PEG, and this in turn can 
provide a shield against the stacking of other nanomaterials, resisting aggregation.  In addition, 
the bulk of the dextran head group may provide better coverage on the surface of the metal, again 
prevent reassociation.  Finally, it may be that by its assembly the Dextran-DSPE is better able to 
encapsulate cylindrical materials than PEG derivatives. 
 
Conclusion 
A singly-bonded conjugate of dextran-17 and DSPE was synthesized and shown to be an 
excellent surfactant for non-covalent functionalization of several nanomaterials for potential 
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biological applications. A single molecule of phospholipid was attached by a synthetic route that 
utilized only the reducing end of dextran, and the amphiphile was found to exhibit a low CMC of 
1.8 µM.  Dextran-DSPE was also found to provide PBS- and serum-stable suspensions of carbon 
nanotubes that were more fluorescent than those with mPEG(5000)-DSPE.  Finally, the Dextran-
DSPE was able to suspend both spherical gold nanoparticles and cylindrical gold nanorods with 
similar stability and with better encapsulation yield than mPEG(5000)-DSPE, most likely due to 
the ability of dextran to cover large areas of the nanomaterial and protect the nanomaterial from 
reaggregating.  Having established Dextran-DSPE as a safe and stable coating of nanomaterials, 
we plan to implement this material for in vivo imaging and therapy applications.  
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